(Q63444324)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Kristi Baker

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Parham Minoo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Daniel Baumhoer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Luigi Terracciano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Alessandro Lugli

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jeremy R Jass

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 February 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

495-502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

Survival rates for stage II colon cancer patients treated with or without chemotherapy in a population-based setting.

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer? For the proposal

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

The surgeon and adjuvant therapy for stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: A potential role for dysregulation of the transforming growth factor-β pathway

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Overexpression of the receptor for hyaluronic acid mediated motility is an independent adverse prognostic factor in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Loss of Raf-1 Kinase Inhibitor Protein Expression Is Associated With Tumor Progression and Metastasis in Colorectal Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Tissue microarrays in drug discovery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Role of APAF-1, E-cadherin and peritumoural lymphocytic infiltration in tumour budding in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Statistics review 13: receiver operating characteristic curves

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Time-dependent ROC curves for censored survival data and a diagnostic marker

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Current issues in adjuvant treatment of stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic role of p27Kip1 deregulation in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Prognostic significance of p27(kip1) protein expression and spontaneous apoptosis in patients with colorectal adenocarcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Quantitative expression of protein markers of plasminogen activation system in prognosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23208

7 January 2021

Identifiers

DOI

10.1002/CNCR.23208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18076013%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference